OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
18
Results
Show all
Save search
Copy query
Show results for
Unknown
(18)
Publication Date
Release Date
2013
(5)
2018
(3)
2014
(3)
2015
(2)
2012
(2)
2024
(1)
2017
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Comprehensive Characterization of Cancer Driver Genes and Mutations.
Not available
S-EPMC6029450
|
biostudies-literature
Cite
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Not available
S-EPMC5916814
|
biostudies-literature
Cite
Characterizing Long COVID in Children and Adolescents.
Not available
S-EPMC11339705
|
biostudies-literature
Cite
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.
Not available
S-EPMC3724194
|
biostudies-literature
Cite
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants.
Not available
S-EPMC3676746
|
biostudies-literature
Cite
Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia.
Not available
S-EPMC3852929
|
biostudies-literature
Cite
Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.
Not available
S-EPMC4129409
|
biostudies-literature
Cite
Rare loss of function variants in candidate genes and risk of colorectal cancer.
Not available
S-EPMC6283057
|
biostudies-literature
Cite
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Not available
S-EPMC4319990
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets